Sites like

mubychem.com
Alternatives

  mubychem.com

noimage.png

Stats

  Alexa Rank: 


  Popular in Country: 


  Country Alexa Rank:  


 language:  


  Response Time:  


  SSL:  Disable


  Status:  up


Code To Txt Ratio

 Word Count  


 Links  


  ratio  


Found 77 Top Alternative to Mubychem.com

1
americanchemicalsuppliers.com.png

Americanchemicalsuppliers.com

USA Chemical Suppliers

Looking for chemicals in America? Search our database to find Suppliers of Raw Materials, Finished Products & Services related to the American Chemical Industry.

3
pharmacopeia.cn.png

Pharmacopeia.cn

USP29-NF24

USP29 1 Front Matter: USP 29 2 Front Matter: NF 24 3 Reference Tables: Description and Solubility - A 4 Reference Tables: Description and Solubility - B 5 Reference Tables: Description and Solubility - C 6 Reference Tables: Description and Solubility - D 7 Reference Tables: Description and Solubility -...

4
noimage.png

Cdhfinechemical.com

Laboratory Fine Chemicals & Culture Media Manufacturer & Exporters in India | CDH Fine Chemical

CDH an ISO 9001:2015 & cGMP certified Manufacturer & Exporters of Laboratory Fine Chemicals, Laboratory Reagents & Dehydrated culture Media in India Since 1981. We provides Laboratory Fine chemicals & Culture Media for Microbiology in domestic & international market.

6
drugfuture.com.png

Drugfuture.com

药物在线-快捷药物信息平台

EMA建议对多发性骨髓瘤新药Tecvayli... EMA已建议在欧盟(EU)对Tecvayli(teclistamab)进行有条件的上市授权,用于治疗复发和难治性多发性骨髓瘤的成年患者,这些患者至少接受过三种先前的治疗,包括免疫调... EMA 建议批准 Imvanex 用于预防猴... EMA 的人类药物委员会 ( CHMP ) 建议扩大天花疫苗Imvanex的适应症,包括保护成年人免受猴痘病的侵害。自 2013 年以来,该药物已在欧盟获批用于预防天花。它含有一种... 药物在线数据库公告 药品标准查询数据库新增日本药典JP18英文版! 药品标准查询数据库新增日本药典JP18日文版! 推荐日本药品橙皮书数据库上线! 药物在线重磅推出日本上市药品数据库! 药物在线之欧盟EMA药品数据库上线! 推荐药物在线之欧盟HMA药品数据库上线! 本站美国FDA药品DMF数据库上线! 推荐美国FDA生物制品紫皮书数据库上线! 药物在线之FDA全球物质注册数据库上线! 推荐Patent9专利在线搜索下载平台! EMA建议对多发性骨髓瘤新药Tecvayli(t22-07-24 EMA 建议批准 Imvanex 用于预防猴痘病22-07-24 EMA建议限制使用癌症药物Rubraca22-07-24 含有诺美雌酚或氯地酮的药物:PRAC建议采取新措22-07-16 EMA建议批准首个治疗严重血友病A的基因疗法22-07-16 FDA批准斑秃(脱发)的首个全身疗法22-06-14 EMA建议撤销苯丙胺酮药物的上市许可22-06-11 EMA发布2021年年度报告22-06-11 专利一站式下载 中国专利全文下载 美国专利全文下载 欧洲专利全文下载 常用药物数据库 美国FDA药品数据库 药品标准查询数据库 中国药品注册数据库 化学物质索引数据库 马丁代尔大药典数据库 药物合成数据库 药用辅料数据库 美国FDA药物非活性成分数据库 化学物质毒性数据库...

Technologies Used by mubychem.com

Dns Records of mubychem.com

A Record: 198.57.244.174
AAAA Record:
CNAME Record:
NS Record: ns2.mubychem.com ns1.mubychem.com
SOA Record: anmolkamdar.yahoo.com
MX Record: d181923b.ess.barracudanetworks.com d181923a.ess.barracudanetworks.com
SRV Record:
TXT Record: v=spf1 ip4:162.241.156.122 +mx +a +ip4:64.235.144.0/20 +ip4:209.222.80.0/21 +ip4:162.214.76.164 +include:websitewelcome.com ~all google-site-verification=IOeG2INAHb7OLx_jAMdZJB9J4t4_0x1OjTqVlc-fxyw
DNSKEY Record:
CAA Record:

Whois Detail of mubychem.com

Domain Name: MUBYCHEM.COM
Registry Domain ID: 191901892_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-12-31T16:36:27Z
Creation Date: 2005-08-01T08:41:24Z
Registry Expiry Date: 2028-08-01T08:41:24Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.MUBYCHEM.COM
Name Server: NS2.MUBYCHEM.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2022-08-23T10:53:07Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.